Back
PubMedBenchmarkClinical pipeline

Systematic assessment of allele dropout in preimplantation genetic testing for monogenic disorders: Incidence, detection, and clinical testing strategies.

Zhang T, Zhang S, He Y, et al.Fertil Steril 2026 · June 2026
Relevance score
7/10
Disease / domain
Preimplantation genetic testing for monogenic disorders (PGT-M)
Source
PubMed
PMID 42288235
Share on LinkedIn

Tool / method

Systematic assessment of allele dropout in PGT-M: incidence, detection, and clinical testing strategies to minimize clinical impact

Summary

This retrospective Fertility and Sterility study systematically evaluates the incidence and clinical implications of allele dropout (ADO) in preimplantation genetic testing for monogenic disorders (PGT-M). ADO — random non-amplification of one of two alleles in a single cell — is a major source of diagnostic error in PGT-M. The authors quantify incidence, evaluate detection methods, and propose practical testing strategies to minimize impact.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

Allele dropout has been known since PGT-M's early days but remains underassessed in daily practice. This systematic evaluation provides reference incidence data and validates practical strategies to improve diagnostic reliability — a direct contribution for laboratories performing PGT-M.

Why this score?

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10

Keywords

PGT-Mallele dropoutpreimplantation diagnosisreproductive geneticsclinical pipeline
Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime